P. Xing

发表

Delivery of tumor associated antigens to antigen presenting cells using penetratin induces potent immune responses.

V. Apostolopoulos, D. Pouniotis, G. Pietersz, 2006, Vaccine.

Monoclonal antibodies to mucin VNTR peptides.

V. Apostolopoulos, I. Mckenzie, P. Xing, 2000, Methods in molecular biology.

Expression of MUC1 and MUC2 mucins by human tumor cell lines.

G. Birrell, R. Whitehead, I. Mckenzie, 1992, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.

Pim-1 associates with protein complexes necessary for mitosis

N. Bhattacharya, N. Magnuson, I. Mckenzie, 2002, Chromosoma.

Cell-Tumor Fusion Cells DendriticProtein 70 Peptide Complexes from Enhanced Immunogenicity of Heat Shock

V. Apostolopoulos, S. Calderwood, Y. Enomoto, 2006 .

MUC1 epithelial mucin (CD227) is expressed by activated dendritic cells

M. McGuckin, S. Gendler, K. MacDonald, 2002, Journal of leukocyte biology.

MUC1-specific immune responses in human MUC1 transgenic mice immunized with various human MUC1 vaccines

V. Apostolopoulos, M. Kieny, D. Wreschner, 2000, Cancer Immunology, Immunotherapy.

Immunohistochemical study of mucin carbohydrates and core proteins in hepatolithiasis and cholangiocarcinoma

K. Imai, S. Yonezawa, E. Sato, 1993, International journal of cancer.

Advances of MUC1 as a target for breast cancer immunotherapy.

E. Yang, P. Xing, X. Hu, 2007, Histology and histopathology.

The immunogenicity of MUC1 peptides and fusion protein.

V. Apostolopoulos, G. Pietersz, P. Xing, 1995, Cancer letters.

Altered glycosylation of the MUC-1 protein core contributes to the colon carcinoma-associated increase of mucin-bound sialyl-Lewis(x) expression.

M. Hanski, C. Hanski, F. Hanisch, 1993, Cancer research.

Expression of MUC2‐mucin in colorectal adenomas and carcinomas of different histological types

H. Stein, M. Stolte, E. Riecken, 1994, International journal of cancer.

Synthetic peptides reactive with anti-human milk fat globule membrane monoclonal antibodies.

J. Tjandra, I. Mckenzie, P. Xing, 1990, Cancer research.

Anti-mucin monoclonal antibodies.

V. Apostolopoulos, G. Pietersz, I. Mckenzie, 2001, Frontiers in bioscience : a journal and virtual library.

Second generation anti-MUC1 peptide monoclonal antibodies.

I. Mckenzie, P. Xing, J. Prenzoska, 1992, Cancer research.

Breast Cancer in Mice: Effect of Murine Muc-1 Immunization on Tumor Incidence in C3H/HeOuj Mice

I. Mckenzie, G. Poulos, P. Xing, 2001, Journal of immunotherapy.

Monoclonal antibodies reactive with mucin expressed in breast cancer

P. Xing, S. Stacker, J. Tjandra, 1989, Immunology and cell biology.

Reactivity of anti-human milk fat globule antibodies with synthetic peptides.

P. McLaughlin, J. Tjandra, D. Purcell, 1989, Journal of immunology.

Mouse mucin 1 (MUC1) defined by monoclonal antibodies

S. Gendler, M. Sandrin, I. Mckenzie, 1998, International journal of cancer.

Expression of MUC2 Gene Product in Mucinous Carcinoma of the Breast: Comparison with Invasive Ductal Carcinoma

Y. S. Kim, M. Nomoto, S. Yonezawa, 1995 .

Peptide epitopes in breast cancer mucins.

V. Apostolopoulos, J. Trapani, I. Mckenzie, 1994, Advances in experimental medicine and biology.

Epitope mapping of anti-breast and anti-ovarian mucin monoclonal antibodies.

I. Mckenzie, P. Xing, J. Prenzoska, 1992, Molecular immunology.

Production of MUC1 and MUC2 mucins by human tumor cell lines.

G. Birrell, I. Mckenzie, P. Xing, 1991, Biochemical and biophysical research communications.

Monoclonal Antibodies Reactive with Breast Cancer, Mammary Mucins and Synthetic Peptides

P. Xing, I. McKenzie, 1991 .

Anti-Cripto Mab inhibit tumour growth and overcome MDR in a human leukaemia MDR cell line by inhibition of Akt and activation of JNK/SAPK and bad death pathways

E. Yang, P. Xing, X. Hu, 2007, British Journal of Cancer.

Distribution of the major xenoantigen (gal (alpha 1-3)gal) for pig to human xenografts.

M. Sandrin, I. Mckenzie, P. Xing, 1994, Transplant immunology.

Mannan-MUC1–Pulsed Dendritic Cell Immunotherapy: A Phase I Trial in Patients with Adenocarcinoma

V. Apostolopoulos, G. Pietersz, B. Loveland, 2006, Clinical Cancer Research.

Mannan-MUC 1 ^ Pulsed Dendritic Cell Immunotherapy : APhase I Trial in Patientswith Adenocarcinoma

G. Pietersz, B. Loveland, H. Gan, 2006 .

Expression of mucin 1 (MUC1) in esophageal squamous‐cell carcinoma: Its relationship with prognosis

S. Natsugoe, T. Aikou, S. Yonezawa, 1999, International journal of cancer.

Murine immune response to cells transfected with human MUC1: immunization with cellular and synthetic antigens.

V. Apostolopoulos, I. Mckenzie, P. Xing, 1994, Cancer research.

Development of a fecal occult blood test using a monoclonal antibody to haptoglobin

I. Mckenzie, P. Xing, G. Young, 2001, Redox report : communications in free radical research.

MUC1 Peptides Presented by Class I H2 and Anti-MUC1 Antibodies React Directly with

G. Chelvanayagam, V. Apostolopoulos, I. Mckenzie, 2017 .

Anti-MUC1 antibodies react directly with MUC1 peptides presented by class I H2 and HLA molecules.

G. Chelvanayagam, V. Apostolopoulos, I. Mckenzie, 1998, Journal of immunology.

MUC 1 Peptides Presented by Class I H 2 and Anti-MUC 1 Antibodies React Directly with and

G. Chelvanayagam, V. Apostolopoulos, I. Mckenzie, 1998 .

Carbohydrate residues downstream of the terminal Galα(1,3)Gal epitope modulate the specificity of xenoreactive antibodies

M. Sandrin, P. Ramsland, I. Mckenzie, 2007, Immunology and cell biology.

The Molecular Basis for Galα(1,3)Gal Expression in Animals with a Deletion of the α1,3Galactosyltransferase Gene12

M. Sandrin, Brooke D. Lazarus, D. Christiansen, 2006, The Journal of Immunology.

Definition and characterization of chicken Gal alpha(1,3)Gal antibodies.

M. Sandrin, I. Mckenzie, J. Smit, 1999, Transplantation.

Oxidised mannan antigen conjugates preferentially stimulate T1 type immune responses.

V. Apostolopoulos, G. Pietersz, P. Xing, 1998, Veterinary immunology and immunopathology.

Comparative studies of the major xenoantigen gal alpha(1,3)gal in pigs and mice.

M. Sandrin, I. Mckenzie, M. Koulmanda, 1995, Transplantation proceedings.

Cripto: a novel target for antibody-based cancer immunotherapy.

G. Pietersz, I. Mckenzie, H. Hosick, 2004, Cancer research.

Characteristics of a breast cancer‐associated antigen defined by RCC‐1 antibody

J. Tjandra, J. Zalcberg, I. Mckenzie, 1990, Immunology and cell biology.

Construction and characterization of a chimeric receptor containing the cytoplasmic domain of MUC1 mucin.

D. Meerzaman, K. C. Kim, P. Xing, 2000, American journal of physiology. Lung cellular and molecular physiology.

CD46 protects pig islets from antibody but not cell‐mediated destruction in the mouse

B. Loveland, M. Sandrin, I. Mckenzie, 2003, Xenotransplantation.

Second-generation monoclonal antibodies to intestinal MUC2 peptide reactive with colon cancer.

I. Mckenzie, P. Xing, P. Devine, 1992, Journal of the National Cancer Institute.

Pim-1 expression and monoclonal antibody targeting in human leukemia cell lines.

J. Li, B. Loveland, P. Xing, 2009, Experimental hematology.

Antibody and T cell responses of patients with adenocarcinoma immunized with mannan-MUC1 fusion protein.

V. Apostolopoulos, G. Pietersz, L. Hwang, 1997, The Journal of clinical investigation.

Correlative histochemical study providing evidence for the dual nature of human colorectal cancer mucin

J. Jass, Y. Hinoda, Y. Ajioka, 2004, The Histochemical Journal.

Expression of MUC2 gene in gastric regenerative, metaplastic, and neoplastic epithelia

F. Itoh, K. Imai, Y. Hinoda, 1999, Journal of clinical laboratory analysis.

Mechanism by Which Orally Administered β-1,3-Glucans Enhance the Tumoricidal Activity of Antitumor Monoclonal Antibodies in Murine Tumor Models1

Jun Yan, G. Ostroff, Jun Yan, 2004, The Journal of Immunology.

Purification and biochemical characterisation of a novel breast carcinoma associated mucin-like glycoprotein defined by antibody 3E1.2.

I. Walker, P. Xing, I. McKenzie, 1989, British Journal of Cancer.

Characterization of a CD46 transgenic pig and protection of transgenic kidneys against hyperacute rejection in non‐immunosuppressed baboons

B. Loveland, I. Mckenzie, D. Christiansen, 2004, Xenotransplantation.

Reply to ‘Response to Milland et al.: Carbohydrate residues downstream of the terminal galα(1,3)gal epitope modulate the specificity of xenoreactive antibodies’

M. Sandrin, P. Ramsland, I. Mckenzie, 2008 .

Pim-1 Kinase Stability Is Regulated by Heat Shock Proteins and the Ubiquitin-Proteasome Pathway

N. Magnuson, I. Mckenzie, P. Xing, 2005, Molecular Cancer Research.

Anti‐peptide monoclonal antibodies to intestinal mucin 3

V. Apostolopoulos, I. Mckenzie, P. Xing, 1995, Journal of gastroenterology and hepatology.

Mucins (MUC1 and MUC3) of Gastrointestinal and Breast Epithelia Reveal Different and Heterogeneous Tumor-associated Aberrations in Glycosylation

B. Ghadimi, Yi Cao, D. Blohm, 1997, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

MUC1 cytoplasmic tail: a potential therapeutic target for ovarian carcinoma

J. Li, E. Yang, P. Xing, 2006, Expert review of anticancer therapy.

The oncogenic serine/threonine kinase Pim-1 directly phosphorylates and activates the G2/M specific phosphatase Cdc25C.

T. Möröy, M. Montenarh, I. Hoffmann, 2006, The international journal of biochemistry & cell biology.

The Oncogenic Serine/Threonine Kinase Pim-1 Phosphorylates and Inhibits the Activity of Cdc25C-associated Kinase 1 (C-TAK1)

T. Möröy, I. Hoffmann, H. Hennemann, 2004, Journal of Biological Chemistry.

Natural human anti-Galα(1,3)Gal antibodies react with human mucin peptides

M. Sandrin, I. Mckenzie, P. Xing, 2004, Glycoconjugate Journal.

Cripto as a target for cancer immunotherapy

P. Xing, X. Hu, 2005, Expert opinion on therapeutic targets.

Enhanced Immunogenicity of Heat Shock Protein 70 Peptide Complexes from Dendritic Cell-Tumor Fusion Cells1

V. Apostolopoulos, S. Calderwood, Y. Enomoto, 2006, The Journal of Immunology.

Production of anti-breast cancer monoclonal antibodies using a glutathione-S-transferase-MUC1 bacterial fusion protein.

V. Apostolopoulos, J. Trapani, P. Xing, 1993, British Journal of Cancer.

Reaction of Antibodies to Human Milk Fat Globule(HMFG) with Synthetic Peptides

J. Tjandra, D. Purcell, I. Mckenzie, 1989 .

Humans with breast cancer have T-cells in their lymph nodes which recognize a peptide sequence within the variable number of tandem repeats of the mammary mucin, MUC1, which is overexpressed in breast

V. Apostolopoulos, I. Mckenzie, P. Xing, 2006 .

Effect of variations in peptide sequence on anti-human milk fat globule membrane antibody reactions.

G. Pietersz, I. Mckenzie, P. Xing, 1991, Immunology.

Peptide Binding Sites Recognized by Anti‐Mucin (MUC2) Monoclonal Antibodies

V. Apostolopoulos, I. Mckenzie, P. Xing, 1993, Scandinavian journal of immunology.

Discrimination between alternatively spliced STP-A and -B isoforms of CD46.

S. Russell, P. Xing, S. Russell, 1994, Immunology.

Overexpression of Cripto and its prognostic significance in breast cancer: a study with long-term survival.

C. Kennedy, B. Lin, S. Y. Kwun, 2007, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

The molecular basis for galalpha(1,3)gal expression in animals with a deletion of the alpha1,3galactosyltransferase gene.

M. Sandrin, Brooke D. Lazarus, D. Christiansen, 2006, Journal of immunology.

Characteristics of immunoglobulin gene usage of the xenoantibody binding to gal-alpha(1,3)gal target antigens in the gal knockout mouse.

V. Starnes, M. Sandrin, I. Mckenzie, 2001, Transplantation.

PIM-1-specific mAb suppresses human and mouse tumor growth by decreasing PIM-1 levels, reducing Akt phosphorylation, and activating apoptosis.

Jie-Hui Li, N. Magnuson, P. Xing, 2009, The Journal of clinical investigation.

Mucin 1 antigens in the serum and bronchial lavage fluid of patients with lung cancer

I. Mckenzie, P. Xing, C. P. Clarke, 1993, Cancer.

Recombinant MUC 1 vaccinia virus: a potential vector for immunotherapy of breast cancer.

D. Spehner, R. Drillien, I. Mckenzie, 1994, Cellular and molecular biology.

Anti‐colorectal carcinoma monoclonal antibodies reactive with human milk fat globular membranes

I. Mckenzie, P. Xing, Jin‐Ghee Teh, 1990, Immunology and cell biology.

Monoclonal antibodies reactive with the breast carcinoma-associated mucin core protein repeat sequence peptide also recognise the ovarian carcinoma-associated sebaceous gland antigen.

I. Mckenzie, P. Xing, P. Devine, 1990, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.

Anti-Pim-1 mAb inhibits activation and proliferation of T lymphocytes and prolongs mouse skin allograft survival.

Jie-Hui Li, B. Loveland, P. Xing, 2011, Cellular immunology.

Discovery and validation of new molecular targets for ovarian cancer.

P. Xing, X. Hu, 2003, Current opinion in molecular therapeutics.

[Relationship between cytokine gene polymorphism and development of gastric adenocarcinoma].

P. Xing, Yun-shan Wang, L. Lü, 2007, Zhonghua yi xue za zhi.

A new approach to fecal occult blood testing based on the detection of haptoglobin

G. Young, P. Høj, I. Mckenzie, 1996, Cancer.

Immunohistochemical detection of MUC2 mucin core protein in ulcerative colitis

H. Akashi, F. Itoh, K. Imai, 1998, Journal of clinical laboratory analysis (Print).

Cripto monoclonal antibodies.

P. Xing, X. Hu, 2005, Drug news & perspectives.

Pig‐to‐human xenotransplantation: The expression of Galα(l–3)Gal epitopes on pig islet cells

M. Sandrin, I. Mckenzie, M. Koulmanda, 1995 .

Effect ofvariations inpeptide sequence on anti-human milkfat globule membraneantibody reactions

G. Pietersz, I. Mckenzie, P. Xing, 1991 .

Glycoconjugate metabolism in a cystic fibrosis knockout mouse model.

J. Bernaudin, J. Capeau, M. Colin, 2001, Molecular genetics and metabolism.